What diseases can cause reticular nodular changes in the lungs and colorectal ulcers or fissures?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 18, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diseases Causing Both Reticular Nodular Lung Changes and Colorectal Ulcers/Fissures

The primary disease that causes both reticular nodular pulmonary changes and colorectal ulcers or fissures is Crohn's disease with pulmonary manifestations. This represents a well-recognized extraintestinal manifestation of inflammatory bowel disease that can affect both organ systems simultaneously or sequentially.

Crohn's Disease with Pulmonary Involvement

Crohn's disease is the most clinically relevant answer to this specific combination of findings, as it is the only condition that directly causes both inflammatory bowel disease (with characteristic colorectal ulcers and fissures) and pulmonary complications with reticular patterns 1.

Pulmonary Manifestations in Crohn's Disease

  • Radiologic findings include bilateral diffuse infiltrates, lung nodules, and ground-glass opacities 1
  • High-resolution CT demonstrates air-trapping, fibrosis, emphysema, bronchiectasis, and alveolitis in approximately 53% of patients 1
  • Histopathologic patterns include chronic bronchiolitis with nonnecrotizing granulomatous inflammation, cellular interstitial pneumonia, and organizing pneumonia with focal granulomatous features 1
  • Cough is the most frequent presenting symptom, occurring in approximately 55% of patients with pulmonary Crohn's disease 1

Timing and Clinical Recognition

  • Pulmonary manifestations can develop years after the diagnosis of Crohn's disease, and in some cases may even precede gastrointestinal symptoms 1
  • In registry data, 85% of patients developed pulmonary features after the onset of inflammatory bowel disease 1
  • This temporal relationship is critical: you may encounter a patient with established Crohn's colitis who later develops reticular lung changes, or conversely, a patient with unexplained interstitial lung disease who subsequently develops colorectal symptoms 1

Gastrointestinal Features

  • Crohn's disease characteristically causes transmural inflammation leading to deep ulcers and fissures in the colorectum 2
  • The ulcers are typically discontinuous (skip lesions) and can be linear or serpiginous 2
  • Fissuring ulcers are a hallmark feature that distinguishes Crohn's from ulcerative colitis 2

Connective Tissue Diseases (Secondary Consideration)

While less likely to cause the specific combination of colorectal fissures, certain autoimmune conditions can affect both systems:

Systemic Sclerosis (SSc)

  • SSc most frequently co-exists with ILD among connective tissue diseases 3
  • Can cause reticular patterns and fibrosis on chest imaging 4, 3
  • However, gastrointestinal involvement typically manifests as dysmotility, esophageal dysfunction, and small bowel bacterial overgrowth rather than ulcers or fissures 3

Other Autoimmune Conditions

  • Rheumatoid arthritis, Sjögren's syndrome, mixed connective tissue disease, and inflammatory myopathies can all cause ILD with reticular patterns 4, 3
  • These conditions rarely cause colorectal ulcers or fissures as a primary manifestation 3
  • When gastrointestinal involvement occurs, it typically presents differently than the ulcers/fissures pattern you're asking about 3

Diagnostic Approach

When Encountering This Combination

First, establish whether the patient has known inflammatory bowel disease:

  • If Crohn's disease is already diagnosed and new pulmonary symptoms or imaging abnormalities develop, strongly consider pulmonary Crohn's disease 1
  • Obtain pulmonary function testing, which reveals abnormalities in approximately 58% of patients 1
  • Before initiating corticosteroids, exclude mesalamine-induced pulmonary toxicity, as this medication is a known cause of lung disease in Crohn's patients 1

If no known IBD, investigate both systems:

  • Perform colonoscopy looking for characteristic Crohn's features: discontinuous inflammation, deep ulcers, fissures, and skip lesions 2
  • Obtain high-resolution chest CT to characterize the reticular pattern and look for associated findings like ground-glass opacities, nodules, or bronchiectasis 1
  • Consider lung biopsy if the diagnosis remains unclear, particularly to exclude other etiologies 1

Critical Pitfalls to Avoid

  • Do not dismiss pulmonary symptoms in a patient with established Crohn's disease as unrelated - pulmonary involvement is a recognized extraintestinal manifestation that requires specific evaluation 1
  • Do not assume all reticular lung changes in IBD patients are drug-induced - while mesalamine toxicity must be excluded, true pulmonary Crohn's disease exists as a distinct entity 1
  • Do not delay systemic corticosteroid therapy once pulmonary Crohn's disease is confirmed - marked improvement occurs with appropriate treatment 1
  • Do not confuse ulcerative colitis with Crohn's disease - ulcerative colitis causes continuous mucosal inflammation without the deep fissuring ulcers characteristic of Crohn's 2

Treatment Considerations

  • Systemic corticosteroid therapy is the cornerstone of treatment for pulmonary Crohn's disease, with marked improvement occurring in patients with interstitial lung disease and necrotic parenchymal nodules 1
  • Treatment must address both the pulmonary and gastrointestinal manifestations simultaneously 1, 2
  • Immunosuppressive therapy may be required for maintenance after initial corticosteroid response 1, 3

References

Guideline

Pulmonary Complications of Crohn's Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.